search
Back to results

Comparison of Mineral Trioxide Aggregate (MTA) and 20% Formocresol (FC) in Pulpotomized Human Primary Molars

Primary Purpose

Dental Caries, Pulpitis

Status
Unknown status
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Gray Mineral Trioxide Aggregate (GMTA)
Diluted (20%) Formocresol (DFC)
Sponsored by
National Taiwan University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dental Caries focused on measuring Mineral Trioxide Aggregate, Formocresol, pulpotomy, primary molar, treatment outcome

Eligibility Criteria

30 Months - 10 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Primary first or second molars with normal pulp, reversible, or irreversible pulpitis, that have vital carious pulp exposures due to caries and whose pulp bled upon entering the pulp chamber.
  • Teeth in which hemostasis could be achieved with pressure of a saline dampened sterile cotton pellet prior to medicament/material placement.
  • No clinical symptoms or evidence of pulp degeneration, such as excessive bleeding from the root canal, history of swelling, mobility, or sinus tracts.
  • Patients with percussion sensitivity or spontaneous and persistent pain but where hemostasis could be achieved with pressure of sterile cotton pellet.
  • No radiographic signs of internal or external root resorption, inter-radicular and/or periapical bone destruction, or furcation radiolucency.
  • No more than one-third physiologic root resorption has occurred.
  • Teeth had not previously been pulpally treated.
  • Teeth deemed to be restorable with posterior stainless steel crowns.

Exclusion Criteria:

  • Not present

Sites / Locations

  • Department of Dentistry, National Taiwan University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

GMTA

20% FC

Arm Description

Outcomes

Primary Outcome Measures

clinically and radiographically outcomes

Secondary Outcome Measures

histological outcome

Full Information

First Posted
September 3, 2009
Last Updated
August 22, 2012
Sponsor
National Taiwan University Hospital
Collaborators
University of Michigan
search

1. Study Identification

Unique Protocol Identification Number
NCT00972556
Brief Title
Comparison of Mineral Trioxide Aggregate (MTA) and 20% Formocresol (FC) in Pulpotomized Human Primary Molars
Official Title
Comparison of Mineral Trioxide Aggregate and 20% Formocresol in Pulpotomized Human Primary Molars :A Long-Term Follow-Up Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2012
Overall Recruitment Status
Unknown status
Study Start Date
September 2009 (undefined)
Primary Completion Date
July 2013 (Anticipated)
Study Completion Date
July 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National Taiwan University Hospital
Collaborators
University of Michigan

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This prospective clinical randomized controlled trial is established to compare the clinical, radiographic, and histological treatment outcomes between MTA and FC in pulpotomized human primary molars at 6, 12, 18, 24 month post-treatment and to test the hypothesis that Gray Mineral Trioxide Aggregate (GMTA) is a viable alternative to Diluted (20%) Formocresol (DFC) in pulpotomies treatment of human primary molars.
Detailed Description
Background: Formocresol (FC) is the most widely used pulpotomy medicament in the primary dentition. There are concerns associated with this medicament, primarily the carcinogenicity of the chemical and internal resorption of the treated tooth. Recently, Mineral Trioxide Aggregate (MTA) has been suggested with preliminary studies showing promising results. Study design: This is a prospective clinical randomized controlled trial (RCT), which will be performed at Department of Dentistry, National Taiwan University Hospital, to compare the treatment outcomes between MTA and FC in pulpotomized human primary molars and to evaluate whether GMTA is a viable alternative to DFC in pulpotomies treatment of human primary molars. Hypotheses: Null Hypotheses: there is no clinical, radiographic, or histological difference between GMTA and DFC at 6, 12, 18, 24 month post-treatment when used as a pulp dressing agent in pulpotomized primary molars. Alternative Hypotheses: There is a statistically significant difference between GMTA and DFC as a pulpotomy agent. GMTA shows clinical and/or radiographic and/or histological success as a dressing material following pulpotomy in primary human molars and may be a suitable replacement for DFC in primary molar pulpotomy. Specific Aims: The primary aims of this investigation are: Compare the clinical and radiographic results of GMTA with DFC pulpotomies on vital human primary molars at 6, 12, 18, and 24 months post-operatively. Assess intraradicular histological changes of the pulpal tissue and root dentin following pulpotomy treatment with GMTA or DFC. The secondary aims of this investigation are: Assess the outcome of GMTA by multiple operators that have been calibrated to the methods of mixing and placing the material. Assess whether sex, tooth type, arch, and age of patient at time of treatment influence the overall success rate of GMTA pulpotomies. Compare the radiographic success of the two materials based on both the traditional radiographic assessment criteria adopted by the American Academy of Pediatric Dentistry (AAPD) and the alternative radiographic success criteria adopted by Zurn et al. 2000. To serve as a basis for future research in the comparison of GMTA and DFC pulpotomies. This will include larger sample size, longer follow-up periods, and a collaborative study with UM group (Prof. Jan C. Hu).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries, Pulpitis
Keywords
Mineral Trioxide Aggregate, Formocresol, pulpotomy, primary molar, treatment outcome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
GMTA
Arm Type
Experimental
Arm Title
20% FC
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
Gray Mineral Trioxide Aggregate (GMTA)
Other Intervention Name(s)
ProRoot MTA
Intervention Description
Once hemorrhage from the pulp chamber is under control using direct pressure of a sterile cotton pellet, pulp stumps are covered with a MTA paste, obtained by mixing 0.2g GMTA powder with sterile water in a powder to liquid ratio of 3:1 in weight. The GMTA will be then immediately covered with a zinc-oxide eugenol base (IRM) material.
Intervention Type
Drug
Intervention Name(s)
Diluted (20%) Formocresol (DFC)
Other Intervention Name(s)
Buckley's Formo Cresol
Intervention Description
After the pulp hemostasis is achieved with direct pressure of a sterile cotton pellet, a sterile cotton pellet dampened with 20% DFC will be placed in contact with the pulp for 5 minutes, followed by the immediate placement of a zinc-oxide eugenol base (IRM) material.
Primary Outcome Measure Information:
Title
clinically and radiographically outcomes
Time Frame
6, 12, 18, and 24 months
Secondary Outcome Measure Information:
Title
histological outcome
Time Frame
when the subjective tooth physically exfoliates from oral cavity

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Months
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Primary first or second molars with normal pulp, reversible, or irreversible pulpitis, that have vital carious pulp exposures due to caries and whose pulp bled upon entering the pulp chamber. Teeth in which hemostasis could be achieved with pressure of a saline dampened sterile cotton pellet prior to medicament/material placement. No clinical symptoms or evidence of pulp degeneration, such as excessive bleeding from the root canal, history of swelling, mobility, or sinus tracts. Patients with percussion sensitivity or spontaneous and persistent pain but where hemostasis could be achieved with pressure of sterile cotton pellet. No radiographic signs of internal or external root resorption, inter-radicular and/or periapical bone destruction, or furcation radiolucency. No more than one-third physiologic root resorption has occurred. Teeth had not previously been pulpally treated. Teeth deemed to be restorable with posterior stainless steel crowns. Exclusion Criteria: Not present
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yuan-Ling Lee, PhD
Phone
886-2-23123456
Ext
67337
Email
yuanlinglee@ntu.edu.tw
First Name & Middle Initial & Last Name or Official Title & Degree
Hsiao-Hua Chang, MS
Phone
886-2-23123456
Ext
70251
Email
hhchangpedo@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yuan-Ling Lee, PhD
Organizational Affiliation
Department of Dentistry, National Taiwan University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Hsiao-Hua Chang, MS
Organizational Affiliation
Department of Dentistry, National Taiwan University Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Dentistry, National Taiwan University Hospital
City
Taipei
ZIP/Postal Code
10048
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yuan-Ling Lee, PhD
Email
yuanlinglee@ntu.edu.tw
First Name & Middle Initial & Last Name & Degree
Hsiao-Hua Chang, MS
Email
hhchangpedo@gmail.com
First Name & Middle Initial & Last Name & Degree
Yuan-Ling Lee, PhD
First Name & Middle Initial & Last Name & Degree
Hsiao-Hua Chang, MS

12. IPD Sharing Statement

Learn more about this trial

Comparison of Mineral Trioxide Aggregate (MTA) and 20% Formocresol (FC) in Pulpotomized Human Primary Molars

We'll reach out to this number within 24 hrs